Article
Immunology
A-Sol Kim, Sung-Min Kim, Ji-Eun Song, Soyoon Hwang, Eunkyung Nam, Ki Tae Kwon
Summary: This study aimed to compare adverse reactions following BNT162b2 and influenza vaccinations in healthcare workers. The study found that the overall adverse reaction rates were significantly higher in the BNT162b2 + IIV4 group and BNT162b2 alone group compared to the IIV4 alone group. Fever, injection site pain, and fatigue were the most common adverse events, with higher occurrence in the BNT162b2 + IIV4 and BNT162b2 alone groups. The study suggests that coadministration of influenza vaccine with BNT162b2 is safe.
Article
Immunology
Ayako Kumabe, Tsuneaki Kenzaka, Shinsuke Yahata, Ken Goda, Masanobu Okayama
Summary: This study investigated the influence of sex, age, and vaccination history on adverse reactions (ARs) to influenza vaccines and their relationship with the risk of influenza infection. The results showed that men and individuals aged >= 60 years were less likely to experience ARs, while those with a history of influenza vaccination had a higher likelihood of ARs. Individuals with ARs, especially localized ones, were more likely to contract influenza infection.
Article
Immunology
Chun-Lan Zhuang, Zhi-Jie Lin, Zhao-Feng Bi, Ling-Xian Qiu, Fang-Fang Hu, Xiao-Hui Liu, Bi-Zhen Lin, Ying-Ying Su, Hui-Rong Pan, Tian-Ying Zhang, Shou-Jie Huang, Yue-Mei Hu, You-Lin Qiao, Feng-Cai Zhu, Ting Wu, Jun Zhang, Ning-Shao Xia
Summary: Concerns over vaccine safety contribute to vaccine hesitancy, but a study found that inflammation-related adverse reactions following vaccination may indicate a stronger immune response. A scoring model was developed to quantify inflammation reactions, with a high score correlating with a robust vaccine-induced antibody level.
EMERGING MICROBES & INFECTIONS
(2021)
Article
Immunology
Sylwia Kalucka, Ewa Kusidel, Agnieszka Glowacka, Paulina Oczos, Izabela Grzegorczyk-Karolak
Summary: This study investigated the vaccination coverage and attitudes of healthcare workers in Poland towards COVID-19 vaccines. The results showed a high vaccination ratio, with doctors and medical students having higher vaccination rates. The main reasons for vaccination were to protect themselves and their families, while the main reasons for avoiding vaccination were fear of side effects and doubts about effectiveness. Side effects were reported by a majority of vaccinated individuals, but were mostly temporary and mild to moderate.
Review
Ophthalmology
John Yu Cheng, Curtis E. Margo
Summary: The Food and Drug Administration has licensed and approved numerous vaccines since 2010, but ocular adverse events can still occur. Common reactions include eyelid and conjunctival issues, while more serious adverse events such as optic neuritis and intraocular inflammation have also been reported.
SURVEY OF OPHTHALMOLOGY
(2022)
Article
Dermatology
Sinee Weschawalit, Padcha Pongcharoen, Worapop Suthiwartnarueput, Winchana Srivilaithon, Kiattichai Daorattanachai, Piyanat Jongrak, Panlop Chakkavittumrong
Summary: This study in Thailand investigated cutaneous adverse reactions (CARs) following COVID-19 vaccination and identified the characteristics of rashes according to vaccine doses or types. The results showed that CARs had a low incidence, were mostly mild and transient, and underlying urticaria and psoriasis were risk factors for CAR development.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY
(2023)
Review
Virology
Katrin Hartmann, Herman Egberink, Karin Moestl, Diane D. Addie, Sandor Belak, Corine Boucraut-Baralon, Tadeusz Frymus, Albert Lloret, Regina Hofmann-Lehmann, Fulvio Marsilio, Maria Grazia Pennisi, Severine Tasker, Etienne Thiry, Uwe Truyen, Margaret J. Hosie
Summary: Vaccine-associated adverse events (VAAEs), such as feline injection-site sarcomas (FISSs), are rare but can be severe. The European Advisory Board on Cat Diseases (ABCD) provides a comprehensive review on VAAEs in cats, summarizing existing knowledge and filling gaps with expert opinions. The causes of VAAEs include immune reactions, local reactions, administration errors, and manufacturing failures. FISS, the most severe VAAE, can occur after vaccinations or other injections. It is important to understand and minimize the risks associated with vaccination.
Review
Immunology
Alexander T. Gallo, Lisa Scanlon, Jade Clifford, Lawson Patten-Williams, Lachlan Tweedie, Dani Li, Sandra M. Salter
Summary: This study retrospectively reviewed immediate adverse events following COVID-19 vaccination in 314 community pharmacies in Australia between July 2021 and June 2022. The most common adverse reaction observed was syncope, and pharmacists appropriately and comprehensively managed both serious and non-serious adverse events.
Article
Rheumatology
Parikshit Sen, Naveen Ravichandran, Arvind Nune, James B. Lilleker, Vishwesh Agarwal, Sinan Kardes, Minchul Kim, Jessica Day, Marcin Milchert, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O'Callaghan, Elena Nikiphorou, Tulika Chatterjee, Ai Lyn Tan, Lorenzo Cavagna, Miguel A. Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Oliver Distler, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta
Summary: This study assessed the safety of COVID-19 vaccines in patients with SAIDs compared to healthy controls. The results showed that SAID patients had a slightly higher risk of minor adverse events compared to the control group, but the absolute risk of major adverse events was small. There were minor differences in adverse events between vaccine types in SAID patients.
Review
Dermatology
Jenna Mistry, Neha Deo, Paul Vance, Afsaneh Alavi
Summary: This study systematically reviewed case reports published between 1995 and 2020 that described cutaneous reactions to the influenza vaccine in adults. A total of 29 studies were included in the final review, and the most frequent cutaneous reactions were erythematous macules/papules/plaques, vasculitic and purpuric rashes, and maculopapular (morbilliform) rashes. Most of the cutaneous manifestations were resolved with treatment, and no further complications were reported upon follow-up.
ADVANCES IN SKIN & WOUND CARE
(2023)
Article
Pharmacology & Pharmacy
Monika Lassanova, Stefan Lassan, Silvia Liskova, Tomas Tesar, Monika Cicova
Summary: This study found an increase in serious adverse reactions after COVID-19 vaccination, with Vaxzevria showing a higher proportion of reported serious adverse reactions.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Immunology
Ana Lilia Peralta-Amaro, Melina Ivone Tejada-Ruiz, Karen Lilian Rivera-Alvarado, Orestes de Jesus Cobos-Quevedo, Patricia Romero-Hernandez, Wiliams Macias-Arroyo, Alberto Avendano-Ponce, Jorge Hurtado-Diaz, Olga Vera-Lastra, Abihai Lucas-Hernandez
Summary: This study presents a case of an 18-year-old patient who developed atypical Kawasaki disease with liver and kidney dysfunction after receiving the COVID-19 vaccine. The patient had a good response to intravenous immunoglobulin therapy. Adverse events following immunization should be reported to facilitate the identification and understanding of similar cases of this disease in adult patients. Case reports play an important role in vaccine pharmacovigilance.
Review
Surgery
Alexander H. Sun, Rafael Felix P. Tiongco, Michele A. Manahan
Summary: This study characterizes adverse events related to COVID-19 vaccines and facial dermal fillers based on data from the FDA's MAUDE database. The findings show a low incidence of these events compared to the large number of vaccine and filler injections administered during the pandemic.
AESTHETIC SURGERY JOURNAL
(2023)
Article
Immunology
Chengwen Luo, Hai-Xiao Chen, Tao-Hsin Tung
Summary: The study found that post-vaccination adverse reactions in healthcare workers could decrease their willingness to take the booster dose. It was noted that HCWs who experienced adverse reactions after vaccination would be more likely to regret their previous vaccination decisions, which further reduced their willingness to receive a booster shot. Decision regret played a mediating role between adverse post-vaccination reactions and willingness to take the booster dose.
Article
Immunology
Erika Bohn-Goldbaum, Yu Sun Bin, Robert Booy, Kate M. Edwards
Summary: This study found that sleep duration was associated with adverse events following immunization (AEFI), while dietary intake, exercise, and smoking habits were not. Factors related to reporting AEFI and influenza-like illness (ILI) included BMI, survey response frequency, sleep quality, and age. Sex stratification revealed that women who experienced AEFI had a higher likelihood of ILI, while in men, survey completion frequency was associated with higher ILI likelihood.
EXPERT REVIEW OF VACCINES
(2022)